Gianni Gromo, M.D., Ph.D.

is a Partner at Versant.

Gianni brings more than two decades of experience in pharmaceutical discovery sciences, and held executive roles at leading global pharmaceutical companies including Roche and Lilly.


Gianni previously was at Roche, where he served as Research Head of Global Cardiovascular and Metabolic Research, and was responsible for all discovery and development activities in the CV, Renal and Metabolic areas; Head of Discovery Research, Basel Site; Global Head of the Metabolic and Vascular Disease Business Unit; and more recently Head of the Roche China R&D center, Shanghai. Gianni brings this depth of experience to Versant portfolio companies by providing critical guidance on their discovery programs.

Getting in touch


Ridgeline Therapeutics GmbH
A Versant Ventures Discovery Engine

Aeschenvorstadt 36

CH 4051 Basel


Offices  and Labs

Ridgeline Therapeutics GmbH
Hochbergerstrasse 60C
CH 4057 Basel

A Versant Ventures Discovery Engine.




Imprint  /  Privacy Policy  /  Terms of Use

© 2018 Ridgeline Therapeutics GmbH,
Ridgeline Discovery GmbH